This Article Full Text Full Text (PDF) All Versions of this Article: 27/10/2258    most recent ATVBAHA.107.149633v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zalewski, J. Articles by Zmudka, K. Search for Related Content PubMed PubMed Citation Articles by Zalewski, J. Articles by Zmudka, K.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2258.)
© 2007 American Heart Association, Inc.

Thrombosis

No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis

Jaroslaw Zalewski; Anetta Undas; Jacek Godlewski; Ewa Stepien; Krzysztof Zmudka

From the Institute of Cardiology (J.Z., A.U., J.G., K.Z.), Jagiellonian University School of Medicine, and John Paul II Hospital (J.Z., J.G., E.S.), Cracow, Poland.

Correspondence to Jaroslaw Zalewski, Institute of Cardiology, Jagiellonian University School of Medicine, John Paul II Hospital, 80 Pradnicka Street, 31-202 Cracow, Poland. E-mail jzalewski{at}szpitaljp2.krakow.pl

Objective— We assessed the relationship between fibrin clot properties and the no-reflow phenomenon after primary coronary intervention (PCI).

Methods and Results— Epicardial blood flow was assessed by TIMI scale and corrected TIMI frame count (cTFC), and perfusion by TIMI Myocardial Perfusion Grade (TMPG) after PCI during ST-segment elevation myocardial infarction (STEMI). Fibrin clot permeability (K_s) and susceptibility to lysis in assays using exogenous thrombin (t_50%) and without thrombin (t_TF) were determined in 30 no-reflow patients (TIMI 2) and in 31 controls (TIMI-3) after uneventful 6 to 14 months from PCI. Patients with TIMI 2 had lower K_s by 18% (P<0.0001) and prolonged fibrinolysis by 33% for t_50% (P<0.0001) and by 45% for t_TF (P<0.0001). cTFC was correlated with K_s (r=–0.56, P<0.0001), t_50% (r=0.49, P<0.001), and t_TF (r=0.54, P<0.001). K_s increased in a stepwise fashion with TIMI flow (P<0.0001) and TMPG (P<0.0001), whereas both fibrinolysis times decreased with TIMI flow (P<0.0001 for both) and TMPG (P<0.01 for both). Multiple regression models showed that only K_s and fibrinogen were independent predictors of cTFC (P<0.05 for both), TIMI 2 flow (P<0.05 for both) and TMPG-0/1 (P<0.05 for both).

Conclusions— Survivors of myocardial infarction with a history of the no-reflow after PCI are characterized with more compact fibrin network and its resistance to lysis.

Fibrin clot properties were assessed in patients after primary coronary angioplasty in acute myocardial infarction. The clots composed of a more compact fibrin network with attenuated fibrinolysis were detected in patients with impaired reperfusion. Reduced clot permeability and fibrinolysis may be a novel prothrombotic mechanism, which might contribute to the pathogenesis of the no-reflow phenomenon.

Key Words: myocardial infarction • primary coronary angioplasty • no-reflow phenomenon • fibrin clot • fibrinolysis

This article has been cited by other articles:

				G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 281 - 292. [Abstract] [Full Text] [PDF]